5th Neuropsychiatric & Psychedelics Drug Development
Evvnt Promotion / evvnt
Archivo
31.10.2022 - 02.11.2022 Crowne Plaza Boston - Woburn, an IHG Hotel, 15 Middlesex Canal Park Rd, 01801 Woburn, USA
Time: 8:15 AM - 4:00 PM
Temas de la conferencia
With reports in depression and anxiety escalating and reaching critical levels, the urgency for developing effective, safe, and fast-acting therapeutics in psychiatry has never been greater. Advances in biomarker development, clinical endpoints, discovery platforms, and modelling have brought us to the precipice of breaking through the historical barriers in psychiatric and psychedelic drug development and into a new era of impactful treatments for this underserved community.
With reports in depression and anxiety escalating and reaching critical levels, the urgency for developing effective, safe, and fast-acting therapeutics in psychiatry has never been greater. Advances in biomarker development, clinical endpoints, discovery platforms, and modelling have brought us to the precipice of breaking through the historical barriers in psychiatric and psychedelic drug development and into a new era of impactful treatments for this underserved community.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Información e inscripción:
https://go.evvnt.com/1252699-2?pid=4832
Ms. Stephanie Nketia
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
